Institution · Emergent BioSolutions (United States)

Most cited papers from Emergent BioSolutions (United States)

Emergent BioSolutions (United States)

What are the most cited papers from Emergent BioSolutions (United States)?

The most cited paper from Emergent BioSolutions (United States) is "Six new loci associated with body mass index highlight a neuronal influence on body weight regulation" (Cristen J. Willer et al., 2008), with 1,733 citations. Next come "A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer" (1,520) and "Genome-wide association study of prostate cancer identifies a second risk locus at 8q24" (1,138).

Published TypeFieldAccessAuthorsCitations

Showing 50 of 60 papers. Every paper with more than 42 citations is listed.

Most cited papers, sortable by citations and release date
#	Paper
1	Six new loci associated with body mass index highlight a neuronal influence on body weight regulation Cristen J. Willer et al. · Nature Genetics Open access145 authors	14 Dec 2008	1,733
2	A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer David John Hunter et al. · Nature Genetics Open access	27 May 2007	1,520
3	Genome-wide association study of prostate cancer identifies a second risk locus at 8q24 Meredith Yeager et al. · Nature Genetics	Apr 2007	1,138
4	Multiple loci identified in a genome-wide association study of prostate cancer Gilles Thomas et al. · Nature Genetics	10 Feb 2008	908
5	A genome-wide association study identifies pancreatic cancer susceptibility loci on chromosomes 13q22.1, 1q32.1 and 5p15.33 Gloria M. Petersen et al. · Nature Genetics Open access	24 Jan 2010	615
6	Identification of ten loci associated with height highlights new biological pathways in human growth The Diabetes Genetics Initiative et al. · Nature Genetics Open access	6 Apr 2008	598
7	A multistage genome-wide association study in breast cancer identifies two new risk alleles at 1p11.2 and 14q24.1 (RAD51L1) Gilles Thomas et al. · Nature Genetics Open access	29 Mar 2009	547
8	Newly discovered breast cancer susceptibility loci on 3p24 and 17q23.2 SEARCH et al. · Nature Genetics Open access138 authors	29 Mar 2009	485
9	Our path to better science in less time using open data science tools Julia Stewart Lowndes, Benjamin D. Best, Courtney Scarborough et al. · Nature Ecology & Evolution Open access	23 May 2017	308
10	Advancing Marine Biological Observations and Data Requirements of the Complementary Essential Ocean Variables (EOVs) and Essential Biodiversity Variables (EBVs) Frameworks Frank E. Muller-Karger et al. · Frontiers in Marine Science Open access	27 Jun 2018	287
11	The Burden of Cryptosporidium Diarrheal Disease among Children < 24 Months of Age in Moderate/High Mortality Regions of Sub-Saharan Africa and South Asia, Utilizing Data from the Global Enteric Multicenter Study (GEMS) Samba Ousmane Sow et al. · PLoS neglected tropical diseases Open access	24 May 2016	272
12	Identification of a new prostate cancer susceptibility locus on chromosome 8q24 Meredith Yeager et al. · Nature Genetics Open access	20 Sep 2009	244
13	Global Observational Needs and Resources for Marine Biodiversity Gabrielle Canonico et al. · Frontiers in Marine Science Open access	23 Jul 2019	156
14	Satellite sensor requirements for monitoring essential biodiversity variables of coastal ecosystems Frank E. Muller-Karger et al. · Ecological Applications Open access	6 Mar 2018	156
15	Tetraspanin CD37 Directly Mediates Transduction of Survival and Apoptotic Signals Rosa Lapalombella et al. · Cancer Cell Open access	May 2012	142
16	In Vitro Profiling of Ceftaroline against a Collection of Recent Bacterial Clinical Isolates from across the United States Yigong Ge, Donald P. Biek, George H. Talbot et al. · Antimicrobial Agents and Chemotherapy Open access	14 Jul 2008	142
17	Sanitation and Hygiene-Specific Risk Factors for Moderate-to-Severe Diarrhea in Young Children in the Global Enteric Multicenter Study, 2007–2011: Case-Control Study Kelly K. Baker et al. · PLoS Medicine Open access	3 May 2016	138
18	Development of multivalent mRNA vaccine candidates for seasonal or pandemic influenza Sudha V. Chivukula et al. · npj Vaccines Open access	16 Dec 2021	121
19	Effect of a Chikungunya Virus–Like Particle Vaccine on Safety and Tolerability Outcomes Grace L. Chen et al. · JAMA Open access	14 Apr 2020	109
20	Effect of Polysorbate 80 on Oritavancin Binding to Plastic Surfaces: Implications for Susceptibility Testing Francis F. Arhin, Ingrid A. Sarmiento, Adam C. Belley et al. · Antimicrobial Agents and Chemotherapy Open access	26 Feb 2008	104
21	"Concordance between comorbidity data from patient self-report interviews and medical record documentation" William D. Corser, Alla E Sikorskii, Ade Olomu et al. · BMC Health Services Research Open access	16 Apr 2008	102
22	Marked enhancement of the immune response to BioThrax® (Anthrax Vaccine Adsorbed) by the TLR9 agonist CPG 7909 in healthy volunteers Dianna L. Rynkiewicz, Melinda McNeal Rathkopf, Iain S. Sim et al. · Vaccine	8 Jun 2011	99
23	NCCN Guidelines Insights: Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Version 2.2019 William G. Wierda et al. · Journal of the National Comprehensive Cancer Network	2019	95
24	Chikungunya virus virus-like particle vaccine safety and immunogenicity in adolescents and adults in the USA: a phase 3, randomised, double-blind, placebo-controlled trial Jason S. Richardson, Deborah M. Anderson, Jason Mendy et al. · The Lancet	30 Mar 2025	90
25	Pan-protective anti-alphavirus human antibodies target a conserved E1 protein epitope Arthur S. Kim et al. · Cell Open access	Aug 2021	86
26	De novo sequencing of sunflower genome for SNP discovery using RAD (Restriction site Associated DNA) approach Venkatramana Pegadaraju, Rick W. Nipper, Brent S. Hulke et al. · BMC Genomics Open access	2013	86
27	A replication-competent adenovirus-vectored influenza vaccine induces durable systemic and mucosal immunity Kenta Matsuda et al. · Journal of Clinical Investigation Open access	2 Feb 2021	85
28	Safety and immunogenicity of PXVX0317, an aluminium hydroxide-adjuvanted chikungunya virus-like particle vaccine: a randomised, double-blind, parallel-group, phase 2 trial Sean Bennett, James M McCarty, Roshan Ramanathan et al. · The Lancet Infectious Diseases	13 Jun 2022	81
29	Safety and immunogenicity of an oral, inactivated, whole-cell vaccine for Shigella sonnei: preclinical studies and a Phase I trial R. McKenzie, Richard I. Walker, Gary S. Nabors et al. · Vaccine	22 Jul 2005	79
30	Stable Intracerebral Transplantation of Neural Stem Cells for the Treatment of Paralysis Due to Ischemic Stroke Guangzhu Zhang, Ying Li, James L. Reuss et al. · Stem Cells Translational Medicine Open access	26 Jun 2019	75
31	Toward the development of a stable, freeze-dried formulation of Helicobacter pylori killed whole cell vaccine adjuvanted with a novel mutant of Escherichia coli heat-labile toxin Nancy A. Summerton, Richard W. Welch, Laureano L. Bondoc et al. · Vaccine Open access	8 Nov 2009	75
32	MOR209/ES414, a Novel Bispecific Antibody Targeting PSMA for the Treatment of Metastatic Castration-Resistant Prostate Cancer Gabriela Hernández‐Hoyos, Toddy Sewell, Robert Bader et al. · Molecular Cancer Therapeutics Open access	12 Jul 2016	72
33	Prolonged evolution of the memory B cell response induced by a replicating adenovirus-influenza H5 vaccine Kenta Matsuda et al. · Science Immunology	12 Apr 2019	71
34	Randomized, double-blind, placebo-controlled, safety and immunogenicity study of 4 formulations of Anthrax Vaccine Adsorbed plus CPG 7909 (AV7909) in healthy adult volunteers Robert J. Hopkins, Nancy Daczkowski, Paulina E. Kaptur et al. · Vaccine Open access	10 May 2013	70
35	N-Substituted Valiolamine Derivatives as Potent Inhibitors of Endoplasmic Reticulum α-Glucosidases I and II with Antiviral Activity Sharanbasappa Shrimant Karade, Michelle L. Hill, J. L. Kiappes et al. · Journal of Medicinal Chemistry Open access	6 Dec 2021	69
36	Interactive effects of changing stratospheric ozone and climate on tropospheric composition and air quality, and the consequences for human and ecosystem health Stephen R. Wilson, Sasha Madronich, Janice D. Longstreth et al. · Photochemical & Photobiological Sciences	27 Feb 2019	69
37	Targeting Endoplasmic Reticulum α-Glucosidase I with a Single-Dose Iminosugar Treatment Protects against Lethal Influenza and Dengue Virus Infections Kelly Lyn Warfield, Dominic S. Alonzi, Johan C. Hill et al. · Journal of Medicinal Chemistry	31 Mar 2020	67
38	In vitro activity profile of ceftobiprole, an anti-MRSA cephalosporin, against recent Gram-positive and Gram-negative isolates of European origin Chris M. Pillar, M.K. Aranza, Dawood Shah et al. · Journal of Antimicrobial Chemotherapy	24 Jan 2008	66
39	Evaluation of Immunogenicity and Efficacy of Anthrax Vaccine Adsorbed for Postexposure Prophylaxis Boris I. Ionin, Robert J. Hopkins, Brett Pleune et al. · Clinical and Vaccine Immunology Open access	9 May 2013	64
40	NCCN Guidelines Insights: Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Version 1.2017 William G. Wierda et al. · Journal of the National Comprehensive Cancer Network Open access	Mar 2017	62
41	Split-inteins and their bioapplications Yifeng Li · Biotechnology Letters	7 Jul 2015	60
42	Extraction of Peppermint Essential Oils and Lipophilic Compounds: Assessment of Process Kinetics and Environmental Impacts with Multiple Techniques Aleksandar Radivojac, Oskar J. Bera, Zoran P. Zeković et al. · Molecules Open access	13 May 2021	59
43	Iminosugars: A host-targeted approach to combat Flaviviridae infections Lisa Evans DeWald, Chloë Starr, Terry D. Butters et al. · Antiviral Research Open access	5 Aug 2020	58
44	Chikungunya virus virus-like particle vaccine safety and immunogenicity in adults older than 65 years: a phase 3, randomised, double-blind, placebo-controlled trial Lauren C. Tindale, Jason S. Richardson, Deborah M. Anderson et al. · The Lancet	30 Mar 2025	57
45	Current Status and Trends in Prophylaxis and Management of Anthrax Disease Vladimir Savransky, Boris I. Ionin, Joshua J. Reece · Pathogens Open access	12 May 2020	57
46	An introduction to the Marburg virus vaccine consortium, MARVAC Robert W. Cross et al. · PLoS Pathogens Open access	13 Oct 2022	56
47	Treating trismus with dynamic splinting: A cohort, case series David H. Shulman, Barry Shipman, F. Buck Willis · Advances in Therapy	2008	55
48	Antimicrobial Susceptibility Profiles Among Common Respiratory Tract Pathogens: A GLOBAL Perspective Daniel F. Sahm · Postgraduate Medicine	15 Sep 2008	54
49	Intranasal administration of BReC-CoV-2 COVID-19 vaccine protects K18-hACE2 mice against lethal SARS-CoV-2 challenge Ting Y. Wong et al. · npj Vaccines Open access	14 Mar 2022	53
50	Iminosugars: Promising therapeutics for influenza infection Beatrice E. Tyrrell, Andrew C. Sayce, Kelly Lyn Warfield et al. · Critical Reviews in Microbiology Open access	8 Dec 2016	53

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.